ELRIG’s Drug Discovery 2025

Hosted again by the City of Liverpool, ELRIG’s Drug Discovery 2025 is Europe’s leading drug discovery and life sciences conference. At this year’s event there will be scientific tracks covering topics including robotics, cell and disease models, ‘omics, AI, oncology and neurodegenerative disease.

The ELRIG conference will host scientific content from partners such as SLAS, the British Pharmacological Society, and the Royal Society of Chemistry. Central to this festival of life sciences is the exhibition hall where attendees have the opportunity to meet with, engage and learn from the leaders in drug discovery as well as leading product suppliers.

ELRIG aims to remove as many barriers to conference attendance as possible, so all events are free to attend and with a faith room, family room and quiet room available, ensuring our promise of inclusivity is at the heart of all our events.

REPROCELL at ELRIG Drug Discovery 2025

REPROCELL will be exhibiting at this show. Please stop by our booth #B07 and say hi to our team: David, Abbie, Nayeem, and Ella-Rose to learn our services.

We look forward to seeing you in Liverpool, UK! Let us tell you about our capabilities. We may be a good partner for your next projects.

Technology Spotlight Company Presentation

• Subject: In vitro and in silico models for sustainable drug discovery
• Presenter: Dr David Bunton, CEO, REPROCELL Europe Ltd.
• Date: October 21st, 14:30
• Location: Auditorium 2

REPROCELL staff at Booth#B07

• Dr David Bunton (david.bunton@reprocell-europe.com)
  CEO, REROCELL Europe Ltd.
• Abbie Wishart (abbie.wishart@reprocell-europe.com)
  Business Development Manager
• Nayeem Hussain (Nayeem.Hussain@reprocell-europe.com)
  Scientific Sales Associate
• Ella-Rose Johnson (Ella-Rose.Johnson@reprocell-europe.com)
  Scientific Sales Associate